The Form 4 filing was filed on November 12, 2026, for trades dated November 9–10, 2026. Form 4 reports changes in an insider's stock ownership. It lists FMR LLC as a 10% owner of Avalyn Pharma (AVLN).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 228,454 |
| Price | $29.33 |
| Total Transaction Value | $6,701,004.23 |
| Insider | |
| Ticker Symbol | AVLN |
| Company | Avalyn Pharma Inc. |
| Insider Name | FMR LLC |
| Insider Title | 10% Owner, Other, See Remark 1 |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 2,056,081 |
| Position Size Change | 10.00% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales by FMR LLC. The four transactions carry code S, which means a sale. The available details do not say whether the shares were sold on a stock exchange or in private deals.
What was the average price of the transaction?
The average sale price was $29.33 per share, rounded to the nearest cent. This average covers the four reported transactions. Individual prices for each trade were not available.
How did this transaction affect the insider's holdings?
After selling 228,454 shares, FMR LLC reported 2,056,081 shares still owned. The shares sold made up 10.00% of its holdings before the sales.
What's the total transaction value?
The four transactions had a total value of $6,701,004.23. This figure covers all the reported sales on November 9–10, 2026.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Footnote text was not available for this report. The listed role also points to Remark 1, but that remark's text was unavailable. These limits leave further details unknown.
For research purposes only; not investment advice.